Phase II trial of the novel epothilone ZK-EPO in patients with platinum resistant ovarian cancer

被引：0
|
作者：
Rustin, G. J.
Reed, N. S.
Jayson, G.
Ledermann, J. A.
Adams, M.
Stredder, C.
Wagner, A.
Giurescu, M.
机构：
[1] Mt Vernon Canc Ctr, Northwood, Middx, England
[2] Beatson Oncol Ctr, Glasgow, Lanark, Scotland
[3] Christie Hosp, Manchester, Lancs, England
[4] UCL, London, England
[5] Velindre Hosp, Cardiff, S Glam, Wales
[6] Schering Hlth Care Ltd, Burgess Hill, W Sussex, England
[7] Bayer Schering Pharma AG, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5527
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II trial of SNS-595 in women with platinum resistant epithelial ovarian cancer
    McGuire, W. P.
    Hirte, H. W.
    Matulonis, U. A.
    Penson, R. T.
    Husain, A.
    Hoskins, P. J.
    Michels, J.
    Michelson, G.
    Chiang, A.
    Aghajanian, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [42] Phase II trial of guadecitabine priming and pembrolizumab in platinum resistant recurrent ovarian cancer.
    Matei, Daniela
    Pant, Alok
    Moroney, John William
    Fleming, Gini F.
    Tanner, Edward
    Swetzig, Wendy M.
    Xu, Jiahui
    Cardenas, Horacio
    Kandpal, Manoj
    Gavrilescu, Andreea
    Chen, Siqi
    Kocherginsky, Masha
    Davuluri, Ramana, V
    Zhang, Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
    Morgan, RJ
    Synold, TW
    Gandara, D
    Muggia, F
    Scudder, S
    Reed, E
    Margolin, K
    Raschko, J
    Leong, L
    Shibata, S
    Tetef, M
    Vasilev, S
    McGonigle, K
    Longmate, J
    Yen, Y
    Chow, W
    Somlo, G
    Carroll, M
    Doroshow, JH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 54 (04) : 283 - 289
  • [44] Phase II study of sagopilone (ZK-EPO) plus prednisone as first-line chemotherapy in patients with metastatic androgen-independent prostate cancer (AIPC)
    Graff, J.
    Smith, D. C.
    Neerukonda, L.
    Alonso, M.
    Jones, G. R.
    Beer, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer
    Zweifel, M.
    Jayson, G. C.
    Reed, N. S.
    Osborne, R.
    Hassan, B.
    Ledermann, J.
    Shreeves, G.
    Poupard, L.
    Lu, S. -P.
    Balkissoon, J.
    Chaplin, D. J.
    Rustin, G. J. S.
    ANNALS OF ONCOLOGY, 2011, 22 (09) : 2036 - 2041
  • [46] Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or - Refractory Ovarian Cancer
    Liu, Joyce F.
    Ray-Coquard, Isabelle
    Selle, Frederic
    Poveda, Andres M.
    Cibula, David
    Hirte, Hal
    Hilpert, Felix
    Raspagliesi, Francesco
    Gladieff, Laurence
    Harter, Philipp
    Siena, Salvatore
    del Campo, Josep Maria
    Tabah-Fisch, Isabelle
    Pearlberg, Joseph
    Moyo, Victor
    Riahi, Kaveh
    Nering, Rachel
    Kubasek, William
    Adiwijaya, Bambang
    Czibere, Akos
    Naumann, R. Wendel
    Coleman, Robert L.
    Vergote, Ignace
    MacBeath, Gavin
    Pujade-Lauraine, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (36) : 4345 - +
  • [47] Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
    Shibani Nicum
    Naomi McGregor
    Rachel Austin
    Linda Collins
    Susan Dutton
    Iain McNeish
    Rosalind Glasspool
    Marcia Hall
    Rene Roux
    Agnieszka Michael
    Andrew Clamp
    Gordon Jayson
    Rebecca Kristeleit
    Susana Banerjee
    Anita Mansouri
    British Journal of Cancer, 2024, 130 : 941 - 950
  • [48] Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer
    Nicum, Shibani
    Mcgregor, Naomi
    Austin, Rachel
    Collins, Linda
    Dutton, Susan
    Mcneish, Iain
    Glasspool, Rosalind
    Hall, Marcia
    Roux, Rene
    Michael, Agnieszka
    Clamp, Andrew
    Jayson, Gordon
    Kristeleit, Rebecca
    Banerjee, Susana
    Mansouri, Anita
    BRITISH JOURNAL OF CANCER, 2024, 130 (06) : 941 - 950
  • [49] Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer
    Cannistra, Stephen A.
    Matulonis, Ursula A.
    Penson, Richard T.
    Hambleton, Julie
    Dupont, Jakob
    Mackey, Howard
    Douglas, Jeffrey
    Burger, Robert A.
    Armstrong, Deborah
    Wenham, Robert
    McGuire, William
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5180 - 5186
  • [50] A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer
    Rischin, D
    Phillips, KA
    Friedlander, M
    Harnett, P
    Quinn, M
    Richardson, G
    Martin, A
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 417 - 421
12345